NEW YORK (Reuters Health) – Patients with angina and multivessel coronary artery disease face poor long-term outcomes with medical management, according to a report in the December issue…
NEW YORK (Reuters Health) – Liver enzyme elevations occur in up to a third of patients with inflammatory arthritis who take methotrexate, leflunomide, or both, a cohort study…
NEW YORK (Reuters Health) – Not only do high-dose statins more effectively prevent first cardiovascular events compared to moderate doses, the higher doses are also better at preventing…
NEW YORK (Reuters Health) – A low platelet count in the presence of hepatitis C viremia indicates the need to begin interferon-based treatment, regardless of the degree of…
NEW YORK (Reuters Health) – Stent-assisted coiling of intracranial aneurysms significantly reduces angiographic recurrence, new research shows. But using stents also increases the risk of permanent neurologic complications…
NEW YORK (Reuters Health) – Despite leading guidelines that suggest clopidogrel be given for 12 months after placement of a drug-eluting stent (DES), patients treated for 6 months…
NEW YORK (Reuters Health) – More than a third of patients undergoing routine outpatient endoscopic procedures are at high risk for obstructive sleep apnea (OSA), according to findings…
NEW YORK (Reuters Health) – Bloodstream infections are more common with the use of needle-free mechanical valve connectors in intravascular catheters, a new study shows. The needle-free mechanical…
NEW YORK (Reuters Health) – In elderly heart failure patients with ejection fractions of 35% or less, implantable cardioverter defibrillators (ICD) can significantly improve long-term survival, according to…
NEW YORK (Reuters Health) – In patients with asymptomatic carotid stenosis (ACS), microemboli and cardiovascular events can be markedly reduced by aggressive medical therapy, Canadian research shows. This…